EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY-NC 3.0

Genetic and Body Composition Factors Associated with Metabolic-Associated Steatotic Liver Disease: A Cross-Sectional Analysis of a Health Screening Cohort

Yi-Hsuan Shen iD, Yi-Chen Lee iD, Tzu-Jung Chou, Hao-Hsiang Chang, Chia-Wen Lu iD, Kuo-Chin Huang iD

Diabetes, Metabolic Syndrome and Obesity · 2026-10 · Volume 19 · 1-12

DOI: 10.2147/dmso.s630425 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Diabetes, Metabolic Syndrome and Obesity, 2026-10. Verfasst von Yi-Hsuan Shen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Metabolic-associated steatotic liver disease (MASLD), newly defined in 2023, is characterized by excessive hepatic triglyceride accumulation in the presence of cardiometabolic risk factors. The body roundness index (BRI), an indicator of body fat distribution and visceral adiposity, has been proposed as a potential predictor of MASLD. Variants in the FTO (fat mass and obesity-associated) gene are well established as genetic determinants of adiposity and metabolic dysfunction. This cross-sectional study aimed to evaluate the predictive value of FTO variants and BRI for MASLD. Material and Methods: This cross-sectional study included 5042 adult men and women aged ≥20 years who underwent self-funded health check-ups and single-nucleotide polymorphism genotyping at the HAVO Health Exam Clinic between January 2020 and December 2021. Participants were classified into the MASLD (n = 2644) and non-MASLD (n = 2398) groups. Hepatic steatosis was diagnosed by abdominal ultrasonography, and MASLD was defined as evidence of hepatic steatosis alongside at least one cardiometabolic risk factor in the absence of other causes of hepatic steatosis. Genotyping was performed using the Global Screening Array-24 v1.0 BeadChip (Infinium, California, USA). Multiple logistic regression models and receiver operating characteristic (ROC) curve analyses were applied to evaluate the predictive performance of the BRI and FTO variants for MASLD.

Results

Among 2644 MASLD and 2398 non-MASLD individuals, the MASLD group had a significantly higher mean BRI (4.08 ± 1.01 vs 2.72 ± 0.69, p < 0.001). Higher BRI quartiles were associated with increased MASLD risk (Q4 OR = 20.50, 95% CI: 13.78-30.51). FTO variants were associated with an elevated BRI (TT: 3.40, AT: 3.54, AA: 3.69, p < 0.001). The AUC for the combined model incorporating both FTO variants and BRI, along with age and sex, in detecting MASLD was 0.907.

Conclusions

The BRI is a strong predictor of MASLD, with FTO risk allele further amplifying susceptibility to MASLD. Integrating genetic and anthropometric markers may enhance MASLD risk assessment.

Schlagwörter

Stichwörter der Autor:innen

FTObody compositionmetabolic-associated steatotic liver diseaseobesity

Autor:innen und Institutionen

  • Department of Dermatology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
  • Department of Family Medicine, National Taiwan University Hospital, Bei-Hu Branch, Taipei, Taiwan.
  • Department of Family Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
  • Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Department of Family Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Department of Family Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.

ORCID-Profile: Yi-Hsuan Shen, Yi-Chen Lee, Chia-Wen Lu, Kuo-Chin Huang

Zitieren

APA

Shen, Y. H., Lee, Y. C., Chou, T. J., Chang, H. H., Lu, C. W., & Huang, K. C. (2026). Genetic and Body Composition Factors Associated with Metabolic-Associated Steatotic Liver Disease: A Cross-Sectional Analysis of a Health Screening Cohort. Diabetes, Metabolic Syndrome and Obesity, Volume 19, 1-12. https://doi.org/10.2147/dmso.s630425

Vancouver

Shen YH, Lee YC, Chou TJ, Chang HH, Lu CW, Huang KC. Genetic and Body Composition Factors Associated with Metabolic-Associated Steatotic Liver Disease: A Cross-Sectional Analysis of a Health Screening Cohort. Diabetes, Metabolic Syndrome and Obesity. 2026;Volume 19:1-12. doi:10.2147/dmso.s630425

BibTeX
@article{Shen2026,
  author = {Shen, Yi-Hsuan and Lee, Yi-Chen and Chou, Tzu-Jung and Chang, Hao-Hsiang and Lu, Chia-Wen and Huang, Kuo-Chin},
  title = {Genetic and Body Composition Factors Associated with Metabolic-Associated Steatotic Liver Disease: A Cross-Sectional Analysis of a Health Screening Cohort},
  journal = {Diabetes, Metabolic Syndrome and Obesity},
  year = {2026},
  volume = {Volume 19},
  pages = {1--12},
  doi = {10.2147/dmso.s630425}
}
Kostenlos starten →